slight clouding of consciousness with focal 
neurological signs such as cranial nerve palsies or 
hemiparesis. In advanced clinical stages, TBM 
presents severe clouding of consciousness or 
delirium, convulsions, and serious neurological signs 
such as hemiplegia, paraplegia, involuntary 
movement (Israni, et al., 2016). 
Tuberculin skin test (Mantoux test) may be 
nonreactive in 50% cases of CNS TB. Hence, it is 
helpful in supporting the diagnosis of TBM when 
positive, but an isolated positive Mantoux cannot be 
used to label a case of TBM, as false positive/false 
negative reactions are commonly known (Aulakh & 
Chopra, 2018). 
Tuberculous meningitis usually presents with a 
Cerebrospinal fluid (CSF) of 10–500 cells/μL that are 
polymorphs initially and lymphocytes later. A low 
glucose <40 mg/dL (rarely<20 mg/dL) or a 
CSF/plasma glucose ratio <50% or a high-protein 
content (400–5000 mg/dL) is suggestive of the 
diagnosis of TBM. The CSF lactate levels are usually 
raised to 5–10 mmol/L (normal range, 1.2–2.1 
mmol/L). Ziehl–Neelsen (ZN) staining for the smear 
examination has a sensitivity of approximately 50%, 
whereas a bacterial culture has a sensitivity of 60% to 
70% (Aulakh & Chopra, 2018). CT scanning and 
MRI of the brain may reveal hydrocephalus, basilar 
meningeal enhancement, infarcts, edema, and 
tuberculomas (Toorn & Solomons, 2014). 
This patient presented with a decreased level of 
consciousness, headache, nuchal rigidity, positive 
Babinski sign, right hemiparesis. TB IGRA was 
positive in this patient. He previously complained of 
cough and fever for two weeks and weight loss for 1 
month.
 
Chest X-ray also showed miliary tuberculosis, 
and the CT of the Brain showed mild hydrocephalus 
which suggests meningitis. From the clinical 
examination, diagnostic tests, this patient can be 
categorized into stage 2 of TBM. 
 WHO recommends a 12-month treatment plan 
(2RHZE/10RH) for children with suspected or 
confirmed TBM (Toorn & Solomons, 2014). We 
gave anti-tuberculosis drugs to this patient according 
to the WHO guideline. Meropenem was given due to 
the possibility of bacterial meningitis that is evidently 
suggested by leukocytosis and increased neutrophil 
count. Hyponatremia occurs in up to 85% of children 
with TBM and is thought to be secondary to either 
syndrome of inappropriate antidiuretic hormone or 
cerebral salt wasting. We also found hyponatremia in 
this patient which was treated with normal saline 
fluid. Corticosteroid oral was given to reduce the risk 
of death and neurological deficit (Toorn & 
Solomons, 2014). 
The patient showed clinical improvement in his 
motoric function after being given an anti-
tuberculosis drug regimen, oral corticosteroid, and 
physiotherapist. 
4 CONCLUSION 
Patients with TBM develop typical symptoms and 
signs of meningitis including headache, fever, and 
stiff neck, although meningeal signs may be absent 
in the early stage. The duration of symptoms before 
presentation ranges from several days to several 
months. In particular, in resource-limited settings, 
TBM cases may present in advanced clinical stages, 
with GCS scores of 10 or less. Cranial nerve palsies, 
hemiparesis, paraparesis, and seizures are common 
and should raise the possibility of tuberculous 
meningitis as the etiology of meningitis (Chin, 
2014). 
This case shows that clinical symptoms of 
tuberculous meningitis can appear as hemiparesis 
without a seizure. Proper treatment of tuberculous 
meningitis may lead to a better outcome. 
REFERENCES
 
Aulakh, R., & Chopra, S. (2018). Pediatric tubercular 
meningitis : A review. J Pediatr Neurosci, 13:373-
82. 
Chin, J. H. (2014, June). Tuberculous Meningitis. 
Neurol Clin Pract, 4(3):199-205. 
doi:10.1212/CPJ.0000000000000023. 
Israni, A. V., Dave, D. A., Mandal, A., Ranjan, R. D., 
Singh, A., & Sahi, P. K. (2016). Tubercular 
meningitis in children: Clinical, pathological, and 
radiological profile and factors associated with 
mortality.  J Neurosci Rural Pract, 7(3):400-404. 
doi:10.4103/0976-3147.181475. 
Rohlwink, U. K., Donald, K., Gavine, B., Padayachy, L., 
Wilmshurst, J. M., Fieggen, G. A., & Figaji, A. A. 
(2016). Clinical characteristics and 
neurodevelopmental outcomes of children with 
tuberculous meningitis and hydrocephalus. 
Developmental Medicine & Child Neurology, 
58:461-468. 
Toorn, R. v., & Solomons, R. (2014). Update on the 
Diagnosis and Management of Tuberculous 
Meningitis in Children. Semin Pediatr Neurol, 
21:12-18. 
Torok, M. (2015, March). Tuberculous meningitis : 
advance in diagnosis and treatment. Br Med Bull, 
113(1):117-31. doi:10.1093/bmb/ldv003. 
WHO. (2018). Global Tuberculosis Report 2018. 
Geneva: World Health Organization.